US OptionsDetailed Quotes

ATNM250117P5000

Watchlist
  • 0.00
  • 0.000.00%
15min DelayClose Jan 17 09:30 ET
0.00High0.00Low
Intraday
  • 5D
  • Daily

No Data

News

Comments

    Trytosaveabit
    Trytosaveabit
    Jan 8 07:26
    Update
    $Actinium (ATNM.US)$ NorthStar Medical Radioisotopes and YAP Therapeutics Enter Into Collaboration Agreement for the Development and Production of Radiopharmaceutical Products
    Businesswire· 13 mins ago
    NorthStar to support the development of YAP Therapeutics' innovative radiolabeled productsThis collaboration merges the expertise and resources from both companies, including NorthStar's state-of-the-art facilitiesThe agreement guarantees that YAP Therapeutics will receive clinical trial-read...
    Trytosaveabit
    Trytosaveabit
    Nov 18, 2024 18:11
    Update
    $Actinium (ATNM.US)$ SK Biopharmaceuticals Seals 1st Actinium-225-Based Collaborative Research Agreement With Korea Institute of Radiological and Medical Sciences as Steps Toward Becoming Global Radiopharmaceutical Therapy Player
    PR Newswire· 10 mins ago
    SK Biopharmaceuticals, Korea Institute of Radiological and Medical Sciences collaborate on discovering and developing radiopharmaceutical drug candidates using an alpha-particleemittingradioisotope, actinium-225, for potential cancer treatm...
    Arrayfunction
    Arrayfunction
    Sep 24, 2024 04:54
    Sadly disappointing Phase 3 results 😞
    $Actinium (ATNM.US)$ Not sure why this didn't pop up on the Moomoo news fees but it's back to another Phase 3 for their AML drug.
    Actinium Announces Publication Of Phase 3 SIERRA Results Of Iomab-B - Quick Facts
    Good lesson on the higher risks of biologics though. BLA (biologics license application) a relatively new classification (maybe 5 or so years?)  meant to divert biologics from the NDA process that small molecule drugs go through.
    In practical terms,...
    Co-Wise: Do you trade the news? Why, or why not?
    Trytosaveabit
    Trytosaveabit
    Sep 20, 2024 07:02
    Update
    $Actinium (ATNM.US)$ Reuters· just
    Actinium Pharmaceuticals Inc - Iomab-B Well Tolerated in Older Relapsed/Refractory Aml Patients
    Trytosaveabit
    Trytosaveabit
    Sep 5, 2024 12:29
    Hmm.
    $Actinium (ATNM.US)$       Abdera Therapeutics Announces FDA Orphan Drug Designation for ABD-147 for the Treatment of Neuroendocrine Carcinoma
    September 05, 2024 08:00 AM Eastern Daylight Time!!! From this morning!  BUT THIS ONE BELOW JUST WAS RELEASED VIA SEEKING ALPHA! NOT SURE IF THEY ARE MISPRINT OF DRUG? OR ANOTHER APPROVAL?
     Perspective gets FDA fast track status for radiopharmaceutical VMT101
Read more